|
DYNLL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.358000E-04 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.11022302462516E-16 |
| Stage1-vs-Stage2 |
2.829600E-04 |
| Stage1-vs-Stage3 |
1.352790E-01 |
| Stage1-vs-Stage4 |
1.563960E-03 |
| Stage2-vs-Stage3 |
1.95922999999265E-05 |
| Stage2-vs-Stage4 |
6.11930000005145E-07 |
| Stage3-vs-Stage4 |
1.203450E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
9.69889999979934E-07 |
| Normal-vs-Asian |
6.48303632999614E-12 |
| Caucasian-vs-AfricanAmerican |
2.827200E-01 |
| Caucasian-vs-Asian |
7.480400E-01 |
| AfricanAmerican-vs-Asian |
2.390600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.54791801177635E-15 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
5.437400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
1.70441438740454E-12 |
| Normal-vs-Age(81-100Yrs) |
8.38539999999943E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.166400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.254000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.930800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.520800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.032400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.434400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.829390E-04 |
| Classical-VS-Follicular |
1.312430E-02 |
| Classical-VS-Other |
4.775000E-01 |
| Classical-VS-Normal |
1.6242562850266E-12 |
| Tall-VS-Follicular |
8.32839999964641E-07 |
| Tall-VS-Other |
5.930200E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.719840E-01 |
| Follicular-VS-Normal |
4.2652000042942E-08 |
| Other-VS-Normal |
1.793030E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.72226685638088E-13 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.53421999999903E-05 |
|
|
